Savings Effect

Sandhar Tech reports #Q4Results Net profit up 49.8% at ₹63.8 cr vs ₹42.6 cr (YoY) Revenue up 29% at ₹1,307 cr vs ₹1,014 cr (YoY) EBITDA up 24.2% at ₹129 cr vs ₹104 cr (YoY) Margin at 9.9% vs 10.2% (YoY)

IRAN DISCUSSING FRAMEWORK, CONFIDENCE-BUILDING STEPS: ISNA

PageInd reports itsQ4 results; 👉Net Profit Up 9% At ₹179 Cr Vs ₹164 Cr (YoY) 👉Revenue Up 14% At ₹1,252.6 Cr Vs ₹1,098 Cr (YoY) 👉EBITDA Up 10.7% At ₹260.4 Cr Vs ₹235.3 Cr (YoY) 👉Margin At 20.8% Vs 21.4% (YoY)

Emami Q4 --Net Profit Down 11.7% At Rs 143 Cr Vs Rs 162 Cr (YoY) --Revenue Down 4% At Rs 925 Cr Vs Rs 963 Cr (YoY) --EBITDA Down 15% At Rs 186.6 Cr Vs Rs 219.4 Cr (YoY) --Margin At 20.2% Vs 23% (YoY)

#Rategain reports its Q4 results; 👉Net Profit Up 28% At ₹70 Cr Vs ₹55 Cr (YoY) 👉Revenue At ₹715.5 Cr Vs ₹260.6 Cr (YoY) 👉EBITDA At ₹147 Cr Vs ₹60.5 Cr (YoY) 👉Margin At 20.5% Vs 23.2% (YoY)

IDBI BANK: GOVERNMENT SOURCES SAY DISCUSSIONS ON THE IDBI BANK DISINVESTMENT PROCESS ARE ONGOING: ETNOW

AURUM PROPTECH: CO BECOMES DEBT-FREE, DOUBLES DOWN ON BUILDING INDIA’S FIRST AI-NATIVE PROPTECH ECOSYSTEM

WEEWORK: CO CEO SAYS FY27 FROM THE STRONGEST OPENING POSITION IN OUR HISTORY, WITH DEEP DEMAND VISIBILITY, STRONG OPERATING LEVERAGE, AND GROWING CONFIDENCE IN THE LONG-TERM MONETISATION POTENTIAL OF THE PLATFORM WE ARE BUILDING

AstraZenecaPharma Gets Govt Nod To Import Calquence Tablets 👉Calquence Tablets Approved For Treatment Of Adult Patients With Mantle Cell Lymphoma

#WeWork reports its Q4 results; 👉Net Profit Up 78% At ₹65 Cr Vs ₹37 Cr (YoY) 👉Revenue Up 27% At ₹705 Cr Vs ₹555 Cr (YoY) 👉EBITDA Up 28% At ₹459 Cr Vs ₹360 Cr (YoY) 👉Margin At 65.1% Vs 64.9% (YoY)

INDIAN ELECTRONICS FEAR DISRUPTION FROM CHINA EXPORT CURBS|| NEW RULES RESTRICT SUPPLY OF CRITICAL MACHINERY AND COMPONENTS: MC

x`JK Lakshmi Cement Guides for ~6% volume growth in FY27, broadly inline with industry growth. Expects cost/tn to rise by ₹150-200 in Q1FY27, near 50% passed on through price hikes Near-term EBITDA/tn uncertain, but aspire to scale towards ₹1000/tn Capex planned at ₹3000 cr, to be executed in phases.

X WITHHOLDS COCKROACH JANTA PARTY ACCOUNT IN INDIA

SUDARSHAN PHARMA: CO APPROVED MIGRATION OF LISTING / TRADING OF THE EQUITY SHARES OF THE CO. FROM SME PLATFORM TO MAIN BOARD OF BSE - SME

SAKAR HEALTHCARE LIMITED: CO. SIGNS 40TH AGREEMENT WITH ZYDUS LIFESCIENCES FOR ONCOLOGY PRODUCTS IN GCC AND EMERGING MARKETS; 23 MA FILINGS IN EU WITH 5 SECURED; 21 APIs DEVELOPED IN-HOUSE; STRATEGY FOCUSED ON BACKWARD INTEGRATION AND REGULATORY CAPABILITIES.

Metro Brands says 👞 Input & freight costs have increased due to the ongoing conflict, which could have a near-term impact on demand but confident on growth preparedness 👟 eCommerce contribution to sustain at 12-15% of sales 🥿 Higher inventory days driven by stock build-up ahead of store openings

Engine Lessor Vs #SpiceJet Engine lessor sunbird France moves Delhi HC, seeks payment of over ₹70 cr from SpiceJet Engine lessor is citing a UK court order of April 2026 directing payment by SpiceJet

DEE Development Q4 --Net Profit Down 11% At Rs 28 Cr Vs Rs 31.5 Cr (YoY) --Revenue Up 26.3% At Rs 362 Cr Vs Rs 286.4 Cr (YoY) --EBITDA Flat At Rs 63.6 Cr (YoY) --Margin At 17.6% Vs 22.2% (YoY)

JSW Cement Q4 --Net Profit At ₹ 371.3 Cr Vs ₹ 34.2 Cr (YoY) --Revenue Up 11% At ₹ 1,895 Cr Vs ₹ 1,709.4 Cr (YoY) --EBITDA Up 52% At ₹ 365 Cr Vs ₹ 240 Cr (YoY) --Margin At 19.3% Vs 14% (YoY) --Tax Write-back At ₹ 147 Cr Vs Expense Of ₹ 59.5 Cr (YoY)

TATA MOTORS PV, JSW MG MOTOR INDIA RECORDS STRONG EV DEMAND || RISING PETROL AND DIESEL PRICES ARE MAKING PEOPLE LOOK AT EVS AS AN AFFORDABLE ALTERNATIVE. - NDTV PROFIT